Crinetics Pharmaceuticals CRNX Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's capital investments accrued but not yet paid?
- Crinetics Pharmaceuticals (CRNX) reported capital investments accrued but not yet paid of $464K in Q1 2026.
- How has Crinetics Pharmaceuticals's capital investments accrued but not yet paid changed year-over-year?
- Crinetics Pharmaceuticals's capital investments accrued but not yet paid increased by 75.8% year-over-year, from $264K to $464K.
- What is the long-term trend for Crinetics Pharmaceuticals's capital investments accrued but not yet paid?
- Over 2 years (2021 to 2023), Crinetics Pharmaceuticals's capital investments accrued but not yet paid has grown at a 159.0% compound annual growth rate (CAGR), from $130K to $872K.